Magnetic resonance imaging (MRI) has shown promise in the assessment of bon
e architecture. The precision and feasibility of MRI measurements in osteop
orosis in vivo have been assessed in this study. T2' was calculated from me
asurements of T2 and T2* in the calcaneus of 32 postmenopausal women using
a gradient-echo sequence PRIME (Partially Refocused Interleaved Multiple Ec
ho). This sequence allows the measurement of T2 and T2* in one acquisition.
In vivo measurements of bone mineral density (BMD) by dual-energy X-ray ab
sorptiometry (DXA) were made in the calcaneus, spine and femoral neck. The
ultrasound parameters broadband ultrasound attenuation (BUA) and speed of s
ound (SOS) were also measured in the calcaneus. These three techniques have
not previously been compared in the same study population. The precision o
f the MRI technique was poor relative to the DXA and ultrasound techniques,
with a CV of 6.9% +/- 4.4% for T2' and 5.5% +/- 3.6% for T2*. Approximatel
y 4% of this is due to system error as determined by phantom measurements.
The postmenopausal women were classified as having low BMD if they had a lu
mbar spine (L2-4) BMD of less than 0.96 g/cm(2) (more than 2 standard devia
tions below normal peak bone mass). Calcaneal T2' was significantly correla
ted with calcaneal BMD (r = -0.79, p < 0.0001), BUA (r = -0.59, p = 0.0004)
and SOS (r= -0.58, p = 0.0006). T2' was significantly different in postmen
opausal women with normal BMD and those with low BMD (p < 0.01). However, t
he difference was of only borderline significance (p < 0.06) after adjustme
nt for age and years since menopause.